🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Status
Unknown
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2016-03
Trial ID
NCT02715362
Treatments Being Tested
This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07523529
The purpose of this study is to determine whether autologous T cells bearin...
Status
Completed
Location
Shanghai Cancer Institute
Start Date
2015-03
Trial ID
NCT02395250
Treatments Being Tested
A Single-arm, Open-label, Multicenter, Phase Ib Clinical Trial to Evaluate ...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2023-10-08
Trial ID
NCT06560827
Treatments Being Tested
This study is designed to determine the safety and efficacy of CAR-GPC3 T c...
Status
Completed
Location
Renji Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2017-03-17
Trial ID
NCT03146234
Treatments Being Tested
This is a single arm, open-label, dose escalation clinical study to evaluat...
Status
Unknown
Location
Tao Zhang
Start Date
2022-03-24
Trial ID
NCT06144385
Treatments Being Tested
The purpose of this study is to observe and confirm the safety, tolerance a...
Status
Unknown
Location
Shanghai Chest Hospital,Shanghai Jiaotong University
Start Date
2016-03
Trial ID
NCT02876978
Treatments Being Tested
This is a single arm, open-label, dose escalation clinical study to evaluat...
Status
Recruiting
Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2023-01-01
Trial ID
NCT05926726
Treatments Being Tested
A phase I clinical study of 4th generation chimeric antigen receptor T Cell...
Status
Recruiting
Location
First Affiliated Hospital, Medical College of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT06461624
Treatments Being Tested
A Phase I Clinical Study of 4th generation Chimeric Antigen Receptor T Cell...
Status
Completed
Location
First affiliated hospital, Zhejiang University
Start Date
2019-07-23
Trial ID
NCT03980288
Treatments Being Tested